Auna S.A.
HealthcareNYSE:AUNA · New York Stock Exchange
-$0.02 today
Vol 0.24M · Avg 0.36M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
6.1%
avg 1.1%
ROIC
5.9%
avg 6.0%
ROA
1.3%
avg 0.7%
Analysis
ROE is currently the strongest return metric at 6.1% versus its period average of 1.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Andres Angel | Executive Vice President of AunaWay implementation & Country Representative in Colombia | — | — | — | — | — |
Jesús Antonio Zamora Leon | President, Chief Executive Officer & Executive Chairman of the Board | — | — | 64 | $69,130.00 | 0.09% |
Laurent Massart | Executive Vice President of Strategy & Equity Capital Markets | — | — | 58 | $0.00 | <0.01% |
Lorenzo Massart | Executive Vice President of Strategy & Equity Capital Markets | — | — | 58 | $0.00 | <0.01% |
Marco Roca | Executive Vice President of Regional Operations & Country Representative of Peru | — | — | — | — | — |
Sven Boes | Executive Vice President of Regional Healthcare Services & Country Representative of Mexico | — | — | — | — | — |
Gisele Remy Ferrero | Chief Financial Officer & Executive Vice President | — | — | 46 | $54,070.00 | 0.07% |
Rayet Harb | Executive Vice President Operations | — | — | 53 | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
6
$357,009.12
Sells
1
$73,302.91
Net Sentiment
+$283,706.21
Net buying
Most Active
Zamora Leon Jesus
6 transactions
Analysis
Insiders reported 6 buys worth $357,009.12 and 1 sells worth $73,302.91 over the last 12 months. That adds up to net buying of $283,706.21. Zamora Leon Jesus was the most active insider with 6 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +30.7% | +23.9% (9yr)3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | +12.1% | +30.1% (9yr)3 analysts |
Analysis
Recent growth has been strongest in Revenue at +30.7% over three years. Forward estimates point to EBIT at +30.1% (9yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Agilon Health, Inc.
NYSE:AGL
$1.88B
Enhabit, Inc.
EHAB
$706.91M
Sonida Senior Living, Inc.
NYSE:SNDA
$700.96M
CeriBell, Inc.
NASDAQ:CBLL
$700.80M
The Oncology Institute, Inc.
NASDAQ:TOI
$530.91M
OrthoPediatrics Corp.
NASDAQ:KIDS
$457.71M
Cross Country Healthcare, Inc.
NASDAQ:CCRN
$434.69M
Autolus Therapeutics plc
NASDAQ:AUTL
$415.18M
Semler Scientific, Inc.
SMLR
$310.75M
Treace Medical Concepts, Inc.
NASDAQ:TMCI
$263.38M
Who manages AUNA?
Auna S.A. (AUNA) lists 8 active executives. The top listed executive is Andres Angel, Executive Vice President of AunaWay implementation & Country Representative in Colombia.
Are AUNA insiders buying or selling?
Recent insider activity shows net buying of $283,706.21.
Explore More
Continue the stock analysis
Jump to another research area for this company.